State Street
NAUT icon

State Street’s Nautilus Biotechnolgy NAUT Stock Holding History

State Street’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
559,508
+343,238
+159% +$906K ﹤0.01% 3460
2026
Q1 		$839K Buy
216,270
+15,015
+7% +$36.9K ﹤0.01% 3523
2025
Q4 		$392K Buy
201,255
+22,500
+13% +$36.9K ﹤0.01% 3742
2025
Q3 		$151K Sell
178,755
-2,861
-2% -$2.1K ﹤0.01% 3974
2025
Q2 		$132K Sell
181,616
-729,215
-80% -$548K ﹤0.01% 3924
2025
Q1 		$784K Sell
910,831
-19,700
-2% -$29.3K ﹤0.01% 3478
2024
Q4 		$1.56M Sell
930,531
-2,400
-0.3% -$5.74K ﹤0.01% 3388
2024
Q3 		$2.66M Sell
932,931
-8,307
-0.9% -$21.5K ﹤0.01% 3223
2024
Q2 		$2.2M Buy
941,238
+3,190
+0.3% +$8.33K ﹤0.01% 3290
2024
Q1 		$2.76M Sell
938,048
-520
-0.1% -$1.48K ﹤0.01% 3170
2023
Q4 		$2.81M Buy
938,568
+885
+0.1% +$2.53K ﹤0.01% 3193
2023
Q3 		$2.96M Buy
937,683
+1,524
+0.2% +$4.96K ﹤0.01% 3157
2023
Q2 		$3.62M Buy
936,159
+221,655
+31% +$639K ﹤0.01% 3155
2023
Q1 		$1.98M Buy
714,504
+12,300
+2% +$25.8K ﹤0.01% 3347
2022
Q4 		$1.26M Buy
702,204
+49,879
+8% +$96.3K ﹤0.01% 3507
2022
Q3 		$1.38M Buy
652,325
+72,142
+12% +$181K ﹤0.01% 3519
2022
Q2 		$1.56M Buy
580,183
+394,228
+212% +$1.47M ﹤0.01% 3534
2022
Q1 		$807K Buy
185,955
+8,755
+5% +$35.9K ﹤0.01% 3873
2021
Q4 		$918K Buy
177,200
+19,500
+12% +$104K ﹤0.01% 3834
2021
Q3 		$968K Buy
+157,700
New +$1.26M ﹤0.01% 3789

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

State Street's NAUT Position: Q2 2026 in Review

State Street increased its Nautilus Biotechnolgy (NAUT) stake by 159% in Q2 2026, buying an estimated $906K and bringing the position to 559,508 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

State Street first reported a position in NAUT in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.62M in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • State Street held 559,508 shares of Nautilus Biotechnolgy worth $1.05M as of Q2 2026.
  • State Street bought 343,238 Nautilus Biotechnolgy shares in Q2 2026, an estimated $906K.
  • Nautilus Biotechnolgy made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3460 holding.
  • State Street first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 20 quarters since.
  • State Street's Nautilus Biotechnolgy position peaked at $3.62M in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.